These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 18559656)
1. Diabetes in patients with idiopathic Parkinson's disease. Becker C; Brobert GP; Johansson S; Jick SS; Meier CR Diabetes Care; 2008 Sep; 31(9):1808-12. PubMed ID: 18559656 [TBL] [Abstract][Full Text] [Related]
2. Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes. Brauer R; Wei L; Ma T; Athauda D; Girges C; Vijiaratnam N; Auld G; Whittlesea C; Wong I; Foltynie T Brain; 2020 Oct; 143(10):3067-3076. PubMed ID: 33011770 [TBL] [Abstract][Full Text] [Related]
3. The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease. Mokhles MM; Trifirò G; Dieleman JP; Haag MD; van Soest EM; Verhamme KM; Mazzaglia G; Herings R; Luise Cd; Ross D; Brusselle G; Colao A; Haverkamp W; Schade R; Camp Gv; Zanettini R; Sturkenboom MC Pharmacol Res; 2012 Mar; 65(3):358-64. PubMed ID: 22123498 [TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease and risk of prostate cancer: A Danish population-based case-control study, 1995-2010. Jespersen CG; Nørgaard M; Borre M Cancer Epidemiol; 2016 Dec; 45():157-161. PubMed ID: 27838564 [TBL] [Abstract][Full Text] [Related]
5. Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies. Huang YF; Cherng YG; Hsu SP; Yeh CC; Chou YC; Wu CH; Chen TL; Liao CC Osteoporos Int; 2015 Jun; 26(6):1723-32. PubMed ID: 25672807 [TBL] [Abstract][Full Text] [Related]
6. Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK. Becker C; Jick SS; Meier CR Drug Saf; 2008; 31(5):399-407. PubMed ID: 18422380 [TBL] [Abstract][Full Text] [Related]
7. Diabetes and the risk of developing Parkinson's disease in Denmark. Schernhammer E; Hansen J; Rugbjerg K; Wermuth L; Ritz B Diabetes Care; 2011 May; 34(5):1102-8. PubMed ID: 21411503 [TBL] [Abstract][Full Text] [Related]
8. Ongoing challenges to finding people with Parkinson's disease for epidemiological studies: a comparison of population-level case ascertainment methods. Harris MA; Koehoorn M; Teschke K Parkinsonism Relat Disord; 2011 Jul; 17(6):464-9. PubMed ID: 21531606 [TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes and the risk of Parkinson's disease. Hu G; Jousilahti P; Bidel S; Antikainen R; Tuomilehto J Diabetes Care; 2007 Apr; 30(4):842-7. PubMed ID: 17251276 [TBL] [Abstract][Full Text] [Related]
10. Obstructive sleep apnea and risk of Parkinson's disease: a population-based cohort study. Chen JC; Tsai TY; Li CY; Hwang JH J Sleep Res; 2015 Aug; 24(4):432-7. PubMed ID: 25810019 [TBL] [Abstract][Full Text] [Related]
11. Risk and course of motor complications in a population-based incident Parkinson's disease cohort. Bjornestad A; Forsaa EB; Pedersen KF; Tysnes OB; Larsen JP; Alves G Parkinsonism Relat Disord; 2016 Jan; 22():48-53. PubMed ID: 26585090 [TBL] [Abstract][Full Text] [Related]
15. Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson's Disease. Molsberry S; Bjornevik K; Hughes KC; Zhang ZJ; Jeanfavre S; Clish C; Healy B; Schwarzschild M; Ascherio A J Parkinsons Dis; 2020; 10(3):1011-1021. PubMed ID: 32250318 [TBL] [Abstract][Full Text] [Related]
16. Increased Prevalence of Polyneuropathy in Parkinson's Disease Patients: An Observational Study. Conradt C; Guo D; Miclea A; Nisslein T; Ismail C; Chatamra K; Andersohn F J Parkinsons Dis; 2018; 8(1):141-144. PubMed ID: 29154292 [TBL] [Abstract][Full Text] [Related]
17. Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude. Sharp ME; Viswanathan J; McKeown MJ; Appel-Cresswell S; Stoessl AJ; Barton JJ Neuropsychologia; 2013 Nov; 51(13):2679-89. PubMed ID: 23954375 [TBL] [Abstract][Full Text] [Related]
18. Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study. Brauer R; Bhaskaran K; Chaturvedi N; Dexter DT; Smeeth L; Douglas I PLoS Med; 2015 Jul; 12(7):e1001854. PubMed ID: 26196151 [TBL] [Abstract][Full Text] [Related]
19. Treatment with levodopa and risk for malignant melanoma. Olsen JH; Tangerud K; Wermuth L; Frederiksen K; Friis S Mov Disord; 2007 Jul; 22(9):1252-7. PubMed ID: 17534943 [TBL] [Abstract][Full Text] [Related]